This site is part of the Siconnects Division of Sciinov Group
This site is operated by a business or businesses owned by Sciinov Group and all copyright resides with them.
ADD THESE DATES TO YOUR E-DIARY OR GOOGLE CALENDAR
Sciinov Group is proud to announce the Oligonucleotide Therapeutics and Delivery Conference, 09-10 June, 2025 in Rome, Italy. This year OTDC 2025 annual Oligonucleotide Therapeutics and Delivery conference will showcase recent advances in oligonucleotide development, regulatory requirements and CMC considerations, strategies to enhance oligonucleotide discovery and targeting and optimised delivery techniques for oligonucleotide-based therapies, in the hope to continue to drive forward the field of oligonucleotide drug development. Join us on the 09-10 June, 2025 at Rome, Italy.
Industry and academic experts ...
We are always looking for new industry leaders to join our speaker faculty to deliver presentations, lead panel discussions and moderate sessions or roundtables.
If you are interested in being considered as a speaker, submit your proposal/abstract Online
We let speakers propose the topic they want to talk about. This process allows speakers to propose sessions that speak from their expertise and passion.
Speaker can choose the topic of your choice in related to the conference subject or any of their recent research work to present at our conference.
For details of scientific sessions covered please visit [not limited to, you can propose]
Please visit the page here
Yes, as our conference is scheduled in Hybrid Mode, you can present and listen to full program virtually connecting via ZOOM live stream
Jun 24
2024
Circulating MicroRNAs Likely as Effective as A1C for Predicting Type 2 Diabetes in Youth
Type 2 diabetes in young people ages 10 to19 has more than doubled in the past 20 years, yet it remains difficult for physicians to predict who will be diagnosed and who will improve with treatment.Readmore
13May
2024
Taking RNAi from interesting science to impactful new treatments
The researchers had done foundational work to understand how RNAi, which is a naturally occurring process, works to silence genes through the degradation of messenger RNA.Readmore
16 JAN
2024
New RNA Therapeutics Core Facility to Drive Cutting-Edge Research
RNA-based technologies, such as the COVID-19 vaccine, are quickly advancing and hold promise to treat diseases ranging from inherited metabolic conditions and autoimmune disorders to cancer and cardiovascular disease.Readmore
22May
2024
Welcome to a brave new world of therapeutics
The field of RNA therapeutics has expanded incredibly over the last 30 years, and mRNA-based COVID-19 vaccines are just the start.Readmore
.jpg.jpg)
Thank you very much for the organization of such an event. I have learned a lot.
Congratulations on the great turnout at the Aging and Gerontology Conference this year!!! I really enjoyed presenting at your event
It was a great experience exchanging views on Aging with speakers from all around the world.
Good day a very nice and informative congress, most of the presentations were very interesting. As a clinical medical doctor i hope some of them can help me in my daily private practice and institutional one. Besides congratulate you for the quality of the Keynote and oral presentations.
Global
By Product (Oligonucleotide-Based Drugs, Synthesized Oligonucleotides, Reagents, and Equipment), Application (Therapeutic Applications, Research Applications, and Diagnostic Applications) and End User (Hospitals, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, CROs and CMOs, Academic Research Institutes)
Global
Market by Type (Synthetic APIs, Natural APIs), by Product Type (Custom Oligonucleotide APIs, Purified Oligonucleotide APIs), by Application (Therapeutic Application, Diagnostic Application) and by End User (Research Laboratories, Academic Institutes, Pharmaceutical Companies)
Global
Report by Products Services (Reagents Kits, Genotyping Services, Bioinformatics Software, Instruments), by Technology (Microarrays, Capillary Electrophoresis, Polymerase Chain Reaction (PCR), Sequencing, MALDI-TOF, Allele Specific Oligonucleotide (ASO) Probes, Others), by Applications (Pharmacogenomics, Animal Genetics, Diagnostic Research, Agricultural Biotechnology, Others) and by End User (Pharmaceutical Biopharmaceutical Companies, Diagnostic Research Laboratories, Academic Institutes)
Global
By Types (Oligonucleotide Synthesis, Gene Synthesis) and by Applications (Hospital, Clinics, Biotech Company, Others)
Global
Market by Product (Enabling Products, DNA Synthesis, Oligonucleotide Synthesis, Enabled Products, Pharmaceuticals, Chemical, Biofuels, Agriculture, Core Products, Synthetic DNA, Synthetic Genes, Synthetic Cells, XNA, Chassis Organisms), by Technology (Enabling Technology, Genome Engineering, Microfluidics technologies, DNA synthesis sequencing technologies, Bioinformatics technologies, Biological components and integrated systems technologies, Enabled Technology, Pathway engineering, Synthetic microbial consortia, Biofuels technologies), by Application (Research Development, Chemicals, Agriculture, Pharmaceuticals Diagnostics, Biofuels, Environment, Biotechnology, Biomaterials, Others) and by End User (Hospitals, Clinics, Others)
.jpeg.jpeg)
.jpeg.jpeg)
